Cel-Sci Corporation(CVM)- NYSEMKT
  • Sharon di Stefano | Send Message 13 Apr

    CEL-SCI's Manufacturing Of Cancer-Killer Multikine Marks A World-Class Facility $CVM http://seekingalpha.com/a/2czfn
      • wilkinson99 | Send Message 24 Mar

        Premarket Top % Losers: $CVM -90%, $PTLA -23%, $SGY -18%, $AM -12%, $MT -6%, $UWTI -6%, $CHK -6% $AGI -5% $ETE $VTAE $IMNP $PLUG
          • Michael Blake Kuritz | Send Message 23 Feb

            welcome to the jungle $CVM
              • Just One Lab Nerd | Send Message 22 Feb

                A Closer Look At Cel-Sci Corporation Going Into Spring Of 2016 $CVM http://seekingalpha.com/a/2bxxw
                  • Just One Lab Nerd | Send Message 5 Jan

                    Cel-Sci Company (CVM) Continues To Slog Forward In Populating Its Phase III Trial For Multikine. $CVM http://seekingalpha.com/p/2seie
                      • Just One Lab Nerd | Send Message 3 Nov 2015

                        Cel-Sci: Phase III Enrollment Numbers Announced, Arbitration Pushed Back, Diutive Financing $CVM http://seekingalpha.com/a/25z5o
                          • Just One Lab Nerd | Send Message 15 Oct 2015

                            Interesting Developments For Cel-Sci's Upcoming Court-Date With Its Former CRO, InVentiv Clinical $CVM http://seekingalpha.com/a/24m1w
                              • Just One Lab Nerd | Send Message 1 Oct 2015

                                Risks And Rewards For Cel-Sci: Phase III And Phase I Progress, And Arbitration $CVM http://seekingalpha.com/a/240e6
                                  • Sharon di Stefano | Send Message 27 Jul 2015

                                    HIV/HPV Guru Comes On Board To Battle Cancer, Driving CEL-SCI's Market Opportunity $CVM http://seekingalpha.com/a/200rv
                                      • Clinically Sound Investor | Send Message 14 May 2015

                                        Cel-Sci: Slightly More Attractive After Dilution $CVM http://seekingalpha.com/a/1w9dq
                                          Company Description
                                          CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases. The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States